Steve Winick

Steve Winick is a Managing Director of Topspin Fund. He came to Topspin in 2004 from Honeywell, Intl., where he most recently served as CIO of its $2B Security Group. He had been with Honeywell (and the Ademco division of Pittway Corp., before its acquisition by Honeywell in 2000) for over 21 years as CTO and CIO of the security business, as well as founder and president of its wireless communications services business. He has served as a Director of Thermolift, Inc., Celmatix, Inc., Setpoint Medical, Inc., Mirimus, Inc., Codagenix Inc, Depymed, Inc. Peloton Therapeutics, and Certerra, Inc. Some of his recent portfolio company exits include ORIC Pharmaceuticals (NASDAQ: ORIC), Alector Pharmaceuticals (NASDAQ: ALEC), Constellation Pharmaceuticals (NASDAQ: CNST), Peloton Therapeutics (acquired by Merck & Co). Steve received a B.S. in Economics from the Wharton School of the University of Pennsylvania in 1971 and a B.S. in Electrical Engineering in 1972, also from Penn. He received his J.D. from Georgetown University Law Center and is both a member of the Bar of the State of New York and a registered Patent Attorney.